ITRON, INC.

(a)No information was required to be disclosed in a report on Form 8-K during the first quarter of 2025 that was not reported.

(b)Not applicable.

(c)Insider Trading Arrangements

Our officers, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934 (the Exchange Act), and directors from time to time enter into contracts, instructions or written plans for the purchase or sale of our securities that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) against liability for trading in securities on the basis of material nonpublic information. During the quarter ended March 31, 2025, the following Section 16 officers adopted, modified, or terminated trading arrangements (as defined in Item 408 of Regulation S-K of the Exchange Act):

•On March 4, 2025, Thomas L. Deitrich, President and Chief Executive Officer, adopted a written trading plan designed to be in effect until February 24, 2026 with respect to the exercise of up to 35,461 stock options of Itron, Inc. common stock, subject to certain conditions.

•On March 4, 2025, John F. Marcolini, Senior Vice President, Networked Solutions, adopted a written trading plan designed to be in effect until September 30, 2025 with respect to the sale of up to 6,904 shares and exercise of up to 3,783 stock options of Itron, Inc. common stock, subject to certain conditions.

•On March 6, 2025, Justin K. Patrick, Senior Vice President, Device Solutions, adopted a written trading plan designed to be in effect until December 31, 2025 with respect to the sale of up to 9,036 shares of Itron, Inc. common stock, subject to certain conditions.